Published in Int J Cancer on April 15, 2001
Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma. Neuro Oncol (2010) 1.78
Gene therapy-mediated delivery of targeted cytotoxins for glioma therapeutics. Proc Natl Acad Sci U S A (2010) 1.29
Challenges in immunotherapy presented by the glioblastoma multiforme microenvironment. Clin Dev Immunol (2011) 1.24
Experimental approaches for the treatment of malignant gliomas. Pharmacol Ther (2010) 1.23
Combining cytotoxic and immune-mediated gene therapy to treat brain tumors. Curr Top Med Chem (2005) 1.09
Gene therapy and targeted toxins for glioma. Curr Gene Ther (2005) 1.02
Gene therapy and targeted toxins for glioma. Curr Gene Ther (2011) 0.97
Identification of interleukin-13 receptor alpha2 chain overexpression in situ in high-grade diffusely infiltrative pediatric brainstem glioma. Neuro Oncol (2008) 0.96
Effect of imaging and catheter characteristics on clinical outcome for patients in the PRECISE study. J Neurooncol (2010) 0.89
Interleukin-13 fusion cytotoxin arrests Schistosoma mansoni egg-induced pulmonary granuloma formation in mice. Am J Pathol (2002) 0.86
Interstitial infusion of glioma-targeted recombinant immunotoxin 8H9scFv-PE38. Mol Cancer Ther (2010) 0.85
Engineering toxin-resistant therapeutic stem cells to treat brain tumors. Stem Cells (2015) 0.85
Histone modification enhances the effectiveness of IL-13 receptor targeted immunotoxin in murine models of human pancreatic cancer. J Transl Med (2011) 0.84
Targeting of interleukin-13 receptor α2 for treatment of head and neck squamous cell carcinoma induced by conditional deletion of TGF-β and PTEN signaling. J Transl Med (2013) 0.84
A novel combination immunotherapy for cancer by IL-13Rα2-targeted DNA vaccine and immunotoxin in murine tumor models. J Immunol (2011) 0.84
Intracellular trafficking considerations in the development of natural ligand-drug molecular conjugates for cancer. Ann Biomed Eng (2011) 0.83
Interleukin-13 receptor α2 DNA prime boost vaccine induces tumor immunity in murine tumor models. J Transl Med (2010) 0.83
Overexpression of interleukin-13 receptor-alpha2 in neuroendocrine malignant pheochromocytoma: a novel target for receptor directed anti-cancer therapy. J Clin Endocrinol Metab (2009) 0.81
Innovative Therapies against Human Glioblastoma Multiforme. ISRN Oncol (2011) 0.81
Targeted toxins for glioblastoma multiforme: pre-clinical studies and clinical implementation. Anticancer Agents Med Chem (2011) 0.77
M2-polarized macrophages contribute to neovasculogenesis, leading to relapse of oral cancer following radiation. Sci Rep (2016) 0.75
Convection-Enhanced Delivery. Neurotherapeutics (2017) 0.75
Improved anti-glioblastoma efficacy by IL-13Rα2 mediated copolymer nanoparticles loaded with paclitaxel. Sci Rep (2015) 0.75
Interleukin-2 receptor gamma chain: a functional component of the interleukin-4 receptor. Science (1993) 4.63
Water supplementation in exclusively breastfed infants during summer in the tropics. Lancet (1991) 2.09
cDNA cloning and characterization of the human interleukin 13 receptor alpha chain. J Biol Chem (1996) 1.68
Interleukin-13 receptor alpha chain: a novel tumor-associated transmembrane protein in primary explants of human malignant gliomas. Cancer Res (2000) 1.55
Ehretianone, a novel quinonoid xanthene from Ehretia buxifolia with antisnake venom activity. J Nat Prod (1996) 1.53
Receptor for interleukin 13. Interaction with interleukin 4 by a mechanism that does not involve the common gamma chain shared by receptors for interleukins 2, 4, 7, 9, and 15. J Biol Chem (1995) 1.52
Human glioma cells overexpress receptors for interleukin 13 and are extremely sensitive to a novel chimeric protein composed of interleukin 13 and pseudomonas exotoxin. Clin Cancer Res (1995) 1.50
Interleukin-4 receptor-directed cytotoxin therapy of AIDS-associated Kaposi's sarcoma tumors in xenograft model. Nat Med (1999) 1.48
Intralesional treatment of established murine primary renal tumor with interleukin-4: localized effect on primary tumor with no impact on metastases. J Urol (1995) 1.44
Analysis of live, oral poliovirus vaccine monopools for human immunodeficiency virus type 1 and simian immunodeficiency virus. J Infect Dis (1996) 1.42
Interleukin-2 toxicity. J Clin Oncol (1991) 1.40
Superiority of acridine orange-stained buffy coat smears for diagnosis of partially treated neonatal septicemia. Acta Paediatr (1993) 1.39
Charter for care of children in hospitals. Indian Pediatr (1991) 1.37
Oral submucous fibrosis--treatment with hyalase. J Laryngol Otol (1985) 1.33
Expression of high affinity interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth in vitro by interleukin-4. J Clin Invest (1993) 1.30
A novel chimeric protein composed of interleukin 13 and Pseudomonas exotoxin is highly cytotoxic to human carcinoma cells expressing receptors for interleukin 13 and interleukin 4. J Biol Chem (1995) 1.30
Novel anti-brain tumor cytotoxins specific for cancer cells. Nat Biotechnol (1998) 1.28
Perinatal mortality-incidence and effect of various maternal factors, Part I. Indian J Pediatr (1982) 1.28
Intratumoral administration of recombinant circularly permuted interleukin-4-Pseudomonas exotoxin in patients with high-grade glioma. Clin Cancer Res (2000) 1.26
IL-13 induces phosphorylation and activation of JAK2 Janus kinase in human colon carcinoma cell lines: similarities between IL-4 and IL-13 signaling. J Immunol (1996) 1.26
Structure of and signal transduction through interleukin-4 and interleukin-13 receptors (review). Int J Mol Med (1998) 1.21
Receptor for interleukin (IL) 13 does not interact with IL4 but receptor for IL4 interacts with IL13 on human glioma cells. J Biol Chem (1996) 1.21
Expression of high-affinity IL-4 receptors on human melanoma, ovarian and breast carcinoma cells. Clin Exp Immunol (1994) 1.19
Two different IL-13 receptor chains are expressed in normal human skin fibroblasts, and IL-4 and IL-13 mediate signal transduction through a common pathway. Int Immunol (1998) 1.15
The IL-13 receptor structure differs on various cell types and may share more than one component with IL-4 receptor. J Immunol (1997) 1.15
Risk factors for fatal diarrhea in hospitalized children in India. J Pediatr Gastroenterol Nutr (1991) 1.08
Structure of IL-13 receptor: analysis of subunit composition in cancer and immune cells. Biochem Biophys Res Commun (1997) 1.06
Receptor for interleukin 13 on AIDS-associated Kaposi's sarcoma cells serves as a new target for a potent Pseudomonas exotoxin-based chimeric toxin protein. Clin Cancer Res (1997) 1.06
Interleukin-13 receptor alpha' but not alpha chain: a functional component of interleukin-4 receptors. Blood (1998) 1.04
IL-10 inhibits HIV-1 replication and is induced by tat. Biochem Biophys Res Commun (1994) 1.04
In situ expression of interleukin-4 (IL-4) receptors in human brain tumors and cytotoxicity of a recombinant IL-4 cytotoxin in primary glioblastoma cell cultures. Cancer Res (2001) 1.02
Interleukin 13 inhibits growth of human renal cell carcinoma cells independently of the p140 interleukin 4 receptor chain. Clin Cancer Res (1996) 1.02
Increased vascular permeability in organs mediated by the systemic administration of lymphokine-activated killer cells and recombinant interleukin-2 in mice. J Natl Cancer Inst (1988) 1.01
Receptors for interleukin (IL)-4 do not associate with the common gamma chain, and IL-4 induces the phosphorylation of JAK2 tyrosine kinase in human colon carcinoma cells. J Biol Chem (1995) 1.00
Polypeptide components of two 8 S forms of chicken oviduct progesterone receptor. J Biol Chem (1984) 1.00
Isolation of steroid receptor binding protein from chicken oviduct and production of monoclonal antibodies. Biochemistry (1985) 0.99
Augmented pulmonary IL-4 and IL-13 receptor subunit expression in idiopathic interstitial pneumonia. J Clin Pathol (2004) 0.99
Phosphorylation in vivo of chicken oviduct progesterone receptor. J Biol Chem (1982) 0.98
Interleukin-13 receptor-targeted cancer therapy in an immunodeficient animal model of human head and neck cancer. Cancer Res (2001) 0.98
Local convection enhanced delivery of IL4-Pseudomonas exotoxin (NBI-3001) for treatment of patients with recurrent malignant glioma. Acta Neurochir Suppl (2003) 0.98
An ultrastructural study of in vivo interactions between lymphocytes and endothelial cells in the pathogenesis of the vascular leak syndrome induced by interleukin-2. Cancer (1991) 0.97
A circularly permuted recombinant interleukin 4 toxin with increased activity. Proc Natl Acad Sci U S A (1994) 0.96
A profile of pyogenic meningitis in children. J Indian Med Assoc (1991) 0.96
Sharing of receptor subunits and signal transduction pathway between the IL-4 and IL-13 receptor system. Int J Hematol (1999) 0.96
Efficacy of serum sialoglycoproteins as a biomarker of the disease activity & treatment monitoring in patients with base tongue malignancy. Indian J Med Res (1989) 0.95
Microbial transformation of primaquine by Candida tropicalis. Appl Environ Microbiol (1984) 0.95
Simple predictors to differentiate acute asthma from ARI in children: implications for refining case management in the ARI Control Programme. Indian Pediatr (1994) 0.94
Rectal histopathology in endemic Shigella and Salmonella diarrhea. J Pediatr Gastroenterol Nutr (1993) 0.94
Overexpressed cell surface interleukin-4 receptor molecules can be successfully targeted for antitumor cytotoxin therapy. Crit Rev Immunol (2001) 0.93
In vivo overexpression of IL-13 receptor alpha2 chain inhibits tumorigenicity of human breast and pancreatic tumors in immunodeficient mice. J Exp Med (2001) 0.93
Sensitization of cancer cells to interleukin 13-pseudomonas exotoxin-induced cell death by gene transfer of interleukin 13 receptor alpha chain. Hum Gene Ther (2000) 0.93
A wide range of human cancers express interleukin 4 (IL4) receptors that can be targeted with chimeric toxin composed of IL4 and Pseudomonas exotoxin. J Biol Chem (1993) 0.91
Human breast carcinoma cells express type II IL-4 receptors and are sensitive to antitumor activity of a chimeric IL-4-Pseudomonas exotoxin fusion protein in vitro and in vivo. Mol Med (2000) 0.90
Identification of distinct roles for a dileucine and a tyrosine internalization motif in the interleukin (IL)-13 binding component IL-13 receptor alpha 2 chain. J Biol Chem (2001) 0.89
Increased antitumor activity of a circularly permuted interleukin 4-toxin in mice with interleukin 4 receptor-bearing human carcinoma. Cancer Res (1995) 0.89
IL-13 fusion cytotoxin ameliorates chronic fungal-induced allergic airway disease in mice. J Immunol (2001) 0.89
Exchange transfusion in neutropenic septicemic neonates: effect on granulocyte functions. Acta Paediatr (1993) 0.88
Structure, function, and targeting of interleukin 4 receptors on human head and neck cancer cells. Cancer Res (2000) 0.88
Infant feeding and child rearing methods in Pondicherry, South India. Indian J Pediatr (1976) 0.88
Mutation and functional analysis of IL-13 receptors in human malignant glioma cells. Oncol Res (2001) 0.88
Interleukin-13 fusion cytotoxin as a potent targeted agent for AIDS-Kaposi's sarcoma xenograft. Blood (2000) 0.87
Complete regression of established human glioblastoma tumor xenograft by interleukin-4 toxin therapy. Cancer Res (1998) 0.87
Childhood morbidity and mortality in a large hospital over last four decades. Indian Pediatr (1991) 0.87
Circularly permuted interleukin 4 retains proliferative and binding activity. Cytokine (1995) 0.87
Systemic treatment with interleukin-4 induces regression of pulmonary metastases in a murine renal cell carcinoma model. Cell Immunol (1995) 0.87
Childhood diarrhoea and its association with enteropathogenic Esch. coli. Indian J Pediatr (1977) 0.87
Potent antitumor activity of IL-13 cytotoxin in human pancreatic tumors engineered to express IL-13 receptor alpha2 chain in vivo. Gene Ther (2003) 0.86
Serum enzyme abnormalities in protein energy malnutrition. Indian Pediatr (1993) 0.86
Simpler tools for peritoneal dialysis of term newborns and young infants. Indian Pediatr (1994) 0.85
Poliomyelitis: 20 years--the Pondicherry experience. J Trop Med Hyg (1989) 0.85
Conversion of interleukin-13 into a high affinity agonist by a single amino acid substitution. J Biol Chem (2000) 0.85
The human immunodeficiency virus type 1 Tat protein potentiates zidovudine-induced cellular toxicity in transgenic mice. Arch Biochem Biophys (1997) 0.85
Growth and major histocompatibility antigen expression regulation by IL-4, interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha) on human renal cell carcinoma. Clin Exp Immunol (1994) 0.84
Human ovarian-carcinoma cell lines express IL-4 and IL-13 receptors: comparison between IL-4- and IL-13-induced signal transduction. Int J Cancer (1997) 0.83
Scorpion evenomation and the role of lytic cocktail in its management. Indian J Pediatr (1982) 0.82
Impact of national immunization schedule on vaccine preventable diseases: a hospital based study. Indian Pediatr (1992) 0.82
Purification of "nontransformed" avian progesterone receptor and preliminary characterization. J Biol Chem (1982) 0.82
Modulation of interleukin (IL)-13 binding and signaling by the gammac chain of the IL-2 receptor. J Biol Chem (1997) 0.82
Production of a novel dimeric metabolite of primaquine by Streptomyces rimosus. Appl Environ Microbiol (1984) 0.82
Gene transfer of interleukin 13 receptor alpha2 chain dramatically enhances the antitumor effect of IL-13 receptor-targeted cytotoxin in human prostate cancer xenografts. Cancer Gene Ther (2001) 0.82
Interleukin-4 receptors expressed on tumor cells may serve as a target for anticancer therapy using chimeric Pseudomonas exotoxin. Int J Cancer (1994) 0.81
Novel way to increase targeting specificity to a human glioblastoma-associated receptor for interleukin 13. Int J Cancer (1998) 0.81
Transcriptional up-regulation of interleukin 4 receptors by human immunodeficiency virus type 1 tat gene. AIDS Res Hum Retroviruses (1996) 0.81
Inhibition of murine renal carcinoma pulmonary metastases by systemic administration of interferon gamma: mechanism of action and potential for combination with interleukin 4. Clin Cancer Res (1997) 0.81
Local anesthetic-phospholipid interactions. The pH dependence of the binding of dibucaine to dimyristoylphosphatidylcholine vesicles. Biochim Biophys Acta (1985) 0.81
Suramin blocks binding of interleukin-4 to its receptors on human tumor cells and interleukin-4-induced mitogenic response. Oncol Res (1995) 0.81
In vivo proliferation of adoptively transferred tumor-infiltrating lymphocytes in mice. J Immunother (1991) (1991) 0.80
Does breastfeeding influence mortality in children hospitalized with diarrhoea? J Trop Pediatr (1991) 0.80
Kinetic analysis of high affinity forms of interleukin (IL)-13 receptors: suppression of IL-13 binding by IL-2 receptor gamma chain. Biophys J (1999) 0.80
Suppression of an IL-13 autocrine growth loop in a human Hodgkin/Reed-Sternberg tumor cell line by a novel IL-13 antagonist. Cell Immunol (2001) 0.80
Transformation of highly purified avian progesterone receptor. Endocrinology (1984) 0.79
Some infant feeding and rearing practices in a rural community in Pondicherry. Indian Pediatr (1974) 0.79